Institutional Ownership Crispr Therapeutics Ag (CRSP)
This table provides information about the institutional ownership of Crispr Therapeutics Ag (CRSP). We have compiled data on the 503 institutions that hold shares in the stock, with a total of 57 Million shares, which have been reported (via 13F filing form) to have a value of $2.94 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Capital International Investors
Los Angeles, CA |
Aug 13, 2024 Q2 2024 |
7,865,253
shares
|
$406 Million
0.09% of portfolio
|
Q2 2024
Added 0.36%
|
|
|
Cathie Wood
Ark Investment Management LLC | St. Petersburg, Fl
|
Oct 31, 2024 Q3 2024 |
7,498,625
shares
|
$387 Million
3.35% of portfolio
|
Q3 2024
Reduced 3.6%
|
|
|
Sumitomo Mitsui Trust Holdings, Inc.
|
Nov 05, 2024 Q3 2024 |
2,968,034
shares
|
$153 Million
0.1% of portfolio
|
Q3 2024
Reduced 5.82%
|
|
|
Nikko Asset Management Americas, Inc.
|
Nov 07, 2024 Q3 2024 |
2,967,219
shares
|
$153 Million
1.61% of portfolio
|
Q3 2024
Reduced 5.85%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,777,784
shares
|
$143 Million
0.0% of portfolio
|
Q2 2024
Added 9.09%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Aug 14, 2024 Q2 2024 |
2,730,652
shares
|
$141 Million
0.09% of portfolio
|
Q2 2024
Added 0.97%
|
|
|
State Street Corp
Boston, MA |
Aug 14, 2024 Q2 2024 |
2,393,684
shares
|
$124 Million
0.01% of portfolio
|
Q2 2024
Added 60.09%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 13, 2024 Q2 2024 |
1,748,513
shares
|
$90.3 Million
0.0% of portfolio
|
Q2 2024
Added 6.83%
|
|
|
Nea Management Company, LLC
Timonium, MD |
Aug 14, 2024 Q2 2024 |
1,587,854
shares
|
$82 Million
8.09% of portfolio
|
Q4 2022
Reduced 0.14%
|
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
1,389,276
shares
|
$71.7 Million
2.65% of portfolio
|
Q1 2024
New holding
|
|
|
Sr One Capital Management, LP
|
Aug 13, 2024 Q2 2024 |
1,048,951
shares
|
$54.1 Million
24.88% of portfolio
|
Q1 2024
New holding
|
|
|
Loomis Sayles & CO L P
|
Aug 13, 2024 Q2 2024 |
1,006,213
shares
|
$51.9 Million
0.07% of portfolio
|
Q2 2024
Reduced 1.86%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 09, 2024 Q2 2024 |
973,018
shares
|
$50.2 Million
0.0% of portfolio
|
Q2 2024
Added 7.01%
|
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2024 Q2 2024 |
941,550
shares
|
$48.6 Million
0.0% of portfolio
|
Q2 2024
Added 9.07%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 07, 2024 Q3 2024 |
824,606
shares
|
$42.6 Million
0.01% of portfolio
|
Q3 2024
Reduced 13.21%
|
|
|
Contrarius Investment Management LTD
St. Helier, Y9 |
Nov 08, 2024 Q3 2024 |
783,898
shares
|
$40.5 Million
2.1% of portfolio
|
Q3 2024
Added 14.32%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
719,309
shares
|
$37.1 Million
0.05% of portfolio
|
Q1 2024
Reduced 17.9%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2024 Q2 2024 |
717,606
shares
|
$37 Million
0.01% of portfolio
|
Q2 2024
Added 7.23%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Aug 13, 2024 Q2 2024 |
693,958
shares
|
$35.8 Million
0.01% of portfolio
|
Q2 2024
Added 528.22%
|
|
|
Norges Bank
Oslo, Q8 |
Aug 14, 2024 Q2 2024 |
650,208
shares
|
$33.6 Million
0.01% of portfolio
|
Q2 2023
Reduced 11.25%
|
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Aug 14, 2024 Q2 2024 |
617,649
shares
|
$31.9 Million
0.56% of portfolio
|
Q2 2024
Reduced 0.37%
|
|
|
Morgan Stanley
New York, NY |
Oct 17, 2024 Q2 2024 |
597,679
shares
|
$30.9 Million
0.0% of portfolio
|
Q2 2024
Reduced 44.96%
|
|
|
Farallon Capital Management LLC
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
530,000
shares
|
$27.4 Million
0.14% of portfolio
|
Q2 2024
New holding
|
|
|
Versant Venture Management, LLC
San Francisco, CA |
Nov 08, 2024 Q3 2024 |
498,558
shares
|
$25.7 Million
61.4% of portfolio
|
Q3 2021
Reduced 1.97%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Aug 08, 2024 Q2 2024 |
447,606
shares
|
$23.1 Million
0.06% of portfolio
|
Q1 2024
Reduced 11.91%
|